Nosipho Ntwanambi

Recent publications · Crossref

5 total works indexed

1. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

   · 2020 · cited 917x

2. Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

   · 2022 · cited 498x

3. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

   · 2025 · cited 357x

4. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

   · 2022 · cited 329x

5. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

   · 2019 · cited 327x

via Crossref · CC0

Wikidata facts